HealthRX.com · Printable question sheet
Egrifta (tesamorelin) questions for prescriber or pharmacist
Use this sheet before a visit with your prescriber or pharmacist about Egrifta (tesamorelin). Record your prescription details, gather monitoring results, and write down questions about approved versus compounded versions, label safety checks and any sport rules that apply to you.
Prescription details
Copy these from the pharmacy label or the carton.
Vial strength as printedCopy exactly from the label
Date the prescription started
Bring to the visit
- Bring the pharmacy label or carton for the current vial
- List your HIV and lipodystrophy diagnosis dates as your chart shows them
- Confirm whether the product is FDA-approved or compounded
- Note any injection site changes or other concerns since the last visit
- Check with the pharmacy whether the vial is the product the prescriber wrote
- Bring any recent blood test results for growth factor and glucose
Questions to ask
- Is my use of Egrifta covered by its approved HIV lipodystrophy use?
- Which blood tests will be checked, and how often will they be repeated?
- What results would lead you to review or stop treatment?
- Is the vial I have an FDA-approved product or a compounded version?
- Does the label say anything about weight loss that applies to my plan?
- What side effects should I report between visits?
- Is there a sport or drug testing rule that applies to me while taking this?
Monitoring results record
Write each result as your clinic reports it.
| Date | Test or check | Result | Question or follow up |
|---|---|---|---|